[HTML][HTML] The dynamics of inflammatory markers in coronavirus disease-2019 (COVID-19) patients: A systematic review and meta-analysis

RK Mahat, S Panda, V Rathore, S Swain… - … epidemiology and global …, 2021 - Elsevier
Abstract Background Coronavirus disease-2019 (COVID-19) is a global pandemic and high
mortality rate among severe or critical COVID-19 is linked with SARS-CoV-2 infection …

Prognostic bioindicators in severe COVID-19 patients

L Bergantini, E Bargagli, M d'Alessandro, RM Refini… - Cytokine, 2021 - Elsevier
Background Severe acute respiratory syndrome caused by novel coronavirus 2 (SARS-CoV-
2) emerged in Wuhan (China) in December 2019. Here we evaluated a panel of biomarkers …

The association between biomarkers and clinical outcomes in novel coronavirus pneumonia in a US cohort

S Ayanian, J Reyes, L Lynn, K Teufel - Biomarkers in Medicine, 2020 - Taylor & Francis
Aim: To describe the association between D-dimer, CRP, IL-6, ferritin, LDH and the clinical
outcomes in a cohort of 299 COVID-19 patients treated on the inpatient medical service at a …

Characterization of the inflammatory response to severe COVID-19 illness

OJ McElvaney, NL McEvoy, OF McElvaney… - American journal of …, 2020 - atsjournals.org
Rationale: Coronavirus disease (COVID-19) is a global threat to health. Its inflammatory
characteristics are incompletely understood. Objectives: To define the cytokine profile of …

[HTML][HTML] Association of inflammatory markers with mortality in COVID-19 infection

AR Arshad, I Khan, K Shahzad, M Arshad, SJ Haider… - Age (years), 2020 - jcpsp.pk
Objective: To evaluate the association of serum ferritin, lactate dehydrogenase, and C-
reactive protein at admission with in-hospital mortality in COVID-19 infection; and to …

[HTML][HTML] Serum interleukin-6, procalcitonin, and C-reactive protein at hospital admission can identify patients at low risk for severe COVID-19 progression

CM Zobel, W Wenzel, JP Krüger… - Frontiers in …, 2023 - frontiersin.org
Background COVID-19 can show a variable course, from asymptomatic infections to acute
respiratory failure and death. For efficient allocation of resources, patients should be …

[HTML][HTML] Immune-inflammatory parameters in COVID-19 cases: a systematic review and meta-analysis

X Feng, S Li, Q Sun, J Zhu, B Chen, M Xiong… - Frontiers in …, 2020 - frontiersin.org
Background: The recent outbreak of coronavirus disease 2019 (COVID-19) has been rapidly
spreading on a global scale and poses a great threat to human health. Acute respiratory …

Laboratory biomarkers associated with COVID-19 severity and management

S Keddie, O Ziff, MKL Chou, RL Taylor, A Heslegrave… - Clinical …, 2020 - Elsevier
The heterogeneous disease course of COVID-19 is unpredictable, ranging from mild self-
limiting symptoms to cytokine storms, acute respiratory distress syndrome (ARDS), multi …

[HTML][HTML] The value of interleukin-6 among several inflammatory markers as a predictor of respiratory failure in COVID-19 patients

M Fujino, M Ishii, T Taniguchi, H Chiba, M Kimata… - Diagnostics, 2021 - mdpi.com
Patients with coronavirus disease 2019 (COVID-19) develop severe respiratory failure within
a short period during the clinical course. It is essential to predict respiratory deterioration in …

[HTML][HTML] A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19)

C Danwang, FT Endomba, JR Nkeck, DLA Wouna… - Biomarker …, 2020 - Springer
Background Prognostic factors for the Coronavirus disease 2019 (COVID1–9) are not well
established. This study aimed to summarize the available data on the association between …